VITAS Awards Innovative Partner of the Year Award to Yale New Haven Health
02/20/2017
Left to right: David Wester, President & CFO of VITAS; Dr. Allen Hsiao, Chief Medical Information Officer of Yale New Haven Health; Israel Perez-Siam, Director of National Accounts at VITAS; & Patrick Hale, Chief Informational Officer & Executive Vice President of VITAS Healthcare
New Haven, CT, February 20, 2017 – VITAS Healthcare, the nation’s leading provider of end-of-life care, has awarded Yale New Haven Health with the Innovative Partner of the Year Award for its innovation and implementation of an interoperability solution. The award was presented at the Healthcare Information and Management Systems Society Annual Meeting in Orlando, Florida. The first-time award recognizes Yale New Haven Health’s best-in-class use of VITAS’ interoperability solution for providers that dramatically reduces the time needed to transition patients from post-acute to hospice care.
“We are honored to receive this award,” said Lisa Stump, senior vice president and CIO of Yale New Haven Health. “This is a positive reflection of our management and care team’s dedication to innovation and hospital solutions that provide our patients with the highest quality of care.”
The Innovative Partner of the Year Award honors VITAS Healthcare partners who have implemented innovative solutions which improve patient care, and set the example for the healthcare community of how information technology can be embraced and applied to benefit patients.
“Our goal with each hospital partnership is to provide a seamless care transition for patients with complex needs,” said David Wester, president and chief financial officer of VITAS Healthcare. “The partnership with Yale New Haven Health has been very successful and we look forward to strengthening our IT solutions for our partners and most importantly, our patients.”
Looking ahead, VITAS is committed to growing the capabilities of the interoperability solution and plans to add a population health data sharing solution aimed at accountable care organizations, managed care organizations, bundle conveners and other risk bearing entities. In addition, the company will team up with leading healthcare analytic providers to better identify hospice-appropriate patients for earlier intervention.